Deep Dive with Lindsay Hill, DNP, PMHNP - Psych NP Mentor - PMHNP Mentor

Deep Dive with Lindsay Hill, DNP, PMHNP - Psych NP Mentor - PMHNP Mentor

Download on the App Store

Deep Dive with Lindsay Hill, DNP, PMHNP - Psych NP Mentor - PMHNP Mentor episodes

  • S2E61: Countertransference as Clinical Data: A PMHNP Field Guide

    Hey! I'd love to hear your thoughts, send me a voice note.

    In this deep-dive episode, we unpack Countertransference as Clinical Data: A PMHNP Field Guide.
    Audio Overview Listen to an in-depth podcast of this post Two hosts break down the full article — no reading required. Your browser does not support audio playback. TL;DR Countertransference is the clinician’s emotional reaction to a patient. It is not a professional failing — it is clinical data. Four reaction patterns (dread, savior pull, boredom, over-familiarity) signal specific diagnostic dynamics. A three-step in-session protocol — Notice, Name, Neutralize — takes under 90 seconds and builds a pattern library over months. Acting on countertransference without supervision is the clinical risk. Having it is not. Early-career PMHNPs who track reactions and bring them to supervision move from reactive to formulated practice within 18 months. In this guide What countertransference actuall
    Read the full post: https://psychnpfellowship.com/countertransference-clinical-data-pmhnp/
    21 min
  • S2E60: Saying No to Controlled Substances: A New PMHNP Confidence Script

    Hey! I'd love to hear your thoughts, send me a voice note.

    In this deep-dive episode, we unpack Saying No to Controlled Substances: A New PMHNP Confidence Script.
    New PMHNPs get pressured, manipulated, and sometimes bullied into writing controlled substances they would not otherwise prescribe. Confidence is not about having a perfect answer — it is about having a rehearsed one. This post delivers a five-step refusal framework, exact patient-facing language, documentation pearls, and the mental reframe that stops most clinicians from caving under pressure.
    Read the full post: https://psychnpfellowship.com/saying-no-controlled-substances-new-pmhnp-confidence-script/
    23 min
  • S2E58: Modern Lithium Monitoring: The 2026 PMHNP Protocol

    Hey! I'd love to hear your thoughts, send me a voice note.

    In this deep-dive episode, we unpack Modern Lithium Monitoring: The 2026 PMHNP Protocol.
    Audio Overview Listen to an in-depth podcast of this post Two hosts break down the full article — no reading required. Your browser does not support audio playback. TL;DR Lithium remains the gold standard for bipolar maintenance and suicide prevention, but the 2026 monitoring protocol has evolved. New PMHNPs should narrow the maintenance target to 0.6-0.8 mEq/L, draw trough levels exactly 12 hours post-dose, screen every patient for GLP-1 agonist use before starting lithium, and coach hydration and sodium behavior as part of the monitoring plan. This post walks through the complete modern protocol — baseline workup, dosing strategy, draw timing, red flags, and the medication interactions that matter most right now. In This Guide Why Lithium Still Wins in 2026 The 2026 Baseline Workup Dosin
    Read the full post: https://psychnpfellowship.com/lithium-monitoring-protocol-pmhnp-2026/
    19 min
  • S2E57: PMHNP Insurance Credentialing: Cut the 120-Day Wait to 45

    Hey! I'd love to hear your thoughts, send me a voice note.

    In this deep-dive episode, we unpack PMHNP Insurance Credentialing: Cut the 120-Day Wait to 45.
    Audio Overview Listen to an in-depth podcast of this post Two hosts break down the full article — no reading required. Your browser does not support audio playback. TL;DR Insurance credentialing for a new PMHNP usually takes 90 to 150 days per payer. A 16-week gap between diploma and first insurance check can cost $60,000 in delayed revenue. Five pre-application moves compress most timelines to 45-60 days. Supervision-required states (TX, FL, PA, others) add a separate approval step. Plan for it. California’s AB 890 independent-practice phase-in is live in 2026. The credentialing packet changed with it. The biggest revenue leak is not the wait. It’s the re-attestation lapse at day 121. In This Post Why the 120-Day Timeline Exists The Real Cost of Waiting The Five Pre-Application Moves What
    Read the full post: https://psychnpfellowship.com/pmhnp-insurance-credentialing-timeline-2026/
    23 min
  • S2E56: Handling Patient Pushback: A New PMHNP’s Confidence Playbook

    Hey! I'd love to hear your thoughts, send me a voice note.

    In this deep-dive episode, we unpack Handling Patient Pushback: A New PMHNP’s Confidence Playbook.
    Audio Overview Listen to an in-depth podcast of this post Two hosts break down the full article — no reading required. Your browser does not support audio playback. TL;DR. New PMHNPs rarely fail because of pharmacology gaps. They stumble when a patient pushes back and the clinician freezes, over-explains, or caves. This playbook shows a 3-step script — Acknowledge, Anchor, Advance — that holds clinical ground, protects the therapeutic alliance, and builds confidence in 60 to 90 days. Includes what most new grads get wrong, a named Fellowship drill, and a 6-question FAQ. In this article Why Patient Pushback Breaks New PMHNPs The Triple-A Script: Acknowledge, Anchor, Advance What Most People Get Wrong About Patient Pushback Four Pushback Scenarios and How to Handle Each The Weekly Debrief Dr
    Read the full post: https://psychnpfellowship.com/handling-patient-pushback-new-pmhnp-confidence-playbook/
    25 min
  • S2E55: Pramipexole for Treatment-Resistant Depression: What PMHNPs Should Know

    Hey! I'd love to hear your thoughts, send me a voice note.

    In this deep-dive episode, we unpack Pramipexole for Treatment-Resistant Depression: What PMHNPs Should Know.
    Audio Overview Listen to an in-depth podcast of this post Two hosts break down the full article — no reading required. Your browser does not support audio playback. TL;DR Pramipexole (Mirapex), a dopamine D3 receptor agonist FDA-approved for Parkinson’s disease, showed strong results in the PAX-D trial published in The Lancet Psychiatry for treatment-resistant unipolar depression. At a target dose of 2.5 mg/day added to existing antidepressants, patients saw significant symptom reduction by week 12, with benefits lasting through 48 weeks. PMHNPs should know the titration protocol, watch for impulse control disorders and nausea, and understand where this fits in the treatment algorithm after two or more failed antidepressant trials. In This Article Why Dopamine Matters in Treatment-Resistan
    Read the full post: https://psychnpfellowship.com/pramipexole-treatment-resistant-depression-pmhnp-guide/
    23 min
  • S2E54: PMHNP Subspecialties: 4 Certifications Worth Pursuing in 2026

    Hey! I'd love to hear your thoughts, send me a voice note.

    In this deep-dive episode, we unpack PMHNP Subspecialties: 4 Certifications Worth Pursuing in 2026.
    Audio Overview Listen to an in-depth podcast of this post Two hosts break down the full article — no reading required. Your browser does not support audio playback. TL;DR The PMHNP-BC opens doors, but subspecialty certifications open better ones. In 2026, four advanced credentials — CARN-AP (addiction), PMH-C (perinatal), PMHS (pediatric), and CPRP (psychiatric rehabilitation) — are creating salary bumps, sharper clinical confidence, and access to specialized roles that generalist PMHNPs can’t touch. This post breaks down each certification, what it takes to earn them, and why early-career PMHNPs should start thinking about specialization now rather than later. In This Post Why Subspecialization Matters Now CARN-AP: Addiction Nursing for Advanced Practice PMH-C: Perinatal Mental Health Cer
    Read the full post: https://psychnpfellowship.com/pmhnp-subspecialty-certifications-2026/
    23 min
  • S2E53: MHPAEA Enforcement 2026: What PMHNPs Need to Know About Mental Health Parity

    Hey! I'd love to hear your thoughts, send me a voice note.

    In this deep-dive episode, we unpack MHPAEA Enforcement 2026: What PMHNPs Need to Know About Mental Health Parity.
    Audio Overview Listen to an in-depth podcast of this post Two hosts break down the full article — no reading required. Your browser does not support audio playback. TL;DR The federal government is cracking down on mental health parity violations in 2026, and the results are staggering: every single health plan analysis reviewed by the Department of Labor failed initial compliance. For PMHNPs, this means new leverage in rate negotiations, stronger grounds for prior authorization appeals, and a shifting insurance environment that could finally close the gap between psychiatric and medical reimbursement. Here’s what you need to know and how to use it. In This Article What Is MHPAEA and Why 2026 Matters The DOL’s 210-Plan Audit: Zero Compliance Prior Authorization Under the Microscope What Thi
    Read the full post: https://psychnpfellowship.com/mhpaea-enforcement-2026-pmhnp-mental-health-parity/
    24 min
  • S2E52: What APA 2026 Means for PMHNPs Right Now

    Hey! I'd love to hear your thoughts, send me a voice note.

    In this deep-dive episode, we unpack What APA 2026 Means for PMHNPs Right Now.
    Audio Overview Listen to an in-depth podcast of this post Two hosts break down the full article — no reading required. Your browser does not support audio playback. 68% of psychiatric providers reported administrative burden as their top practice barrier in 2025. The American Psychiatric Association chose its 2026 Annual Meeting theme in response: “Empowering the Psychiatric Workforce: Taking Control of Our Practices One Step at a Time.” The meeting runs May 16–20 in San Francisco, with over 400 sessions and 1,000 poster presentations across eight tracks. But the theme itself tells a bigger story about where psychiatric care is heading. And PMHNPs sit right at the center of that shift. “When the largest psychiatric organization in the country names workforce empowerment as its annual prior
    Read the full post: https://psychnpfellowship.com/what-apa-2026-means-for-pmhnps/
    9 min
  • S2E51: DEA Telehealth Prescribing in 2026: What PMHNPs Must Know

    Hey! I'd love to hear your thoughts, send me a voice note.

    In this deep-dive episode, we unpack DEA Telehealth Prescribing in 2026: What PMHNPs Must Know.
    Audio Overview Listen to an in-depth podcast of this post Two hosts break down the full article — no reading required. Your browser does not support audio playback. The clock is ticking on one of the most consequential regulatory deadlines in psychiatric telehealth. On December 31, 2026, the DEA’s fourth temporary extension of pandemic-era telehealth prescribing flexibilities is set to expire — and permanent rules remain unfinished. For PMHNPs who prescribe Schedule II–V controlled substances via telehealth, the next eight months demand strategic preparation. Roughly 137 million Americans live in designated mental health professional shortage areas. Telehealth has been the bridge connecting those patients to psychiatric care. But the regulatory scaffolding holding that bridge together was
    Read the full post: https://psychnpfellowship.com/dea-telehealth-prescribing-rules-pmhnp-2026/
    20 min

About Deep Dive with Lindsay Hill, DNP, PMHNP - Psych NP Mentor - PMHNP Mentor

From the publisher's feed

Welcome to my podcast. I am Lindsay Hill, DNP, PMHNP BC, and this show is my space to slow down and really unpack what psychiatric care looks like in real life.

Each episode is built from the…